• 11/27/2023, Sophia Antipolis, France

    Median Technologies selected for support under the French government’s ETIncelles program.

    Median Technologies has been chosen to join the ETIncelles scheme, an initiative created by the President of the French Republic, which aims to help 500 high growth potential SMEs (Small and Medium-sized Enterprises) in their transition to becoming an ETI (Intermediate-Sized Enterprise), by 2027. The ETIncelles program helps SMEs identify obstacles to their growth, especially administrative aspects, with the aim of better overcoming them and acting as a catalyst for their development and conversion into an intermediate-sized enterprise.
    Read more Download 20231127_PR_ETIncelles_EN_FV.pdf
  • 11/26/2023, Sophia Antipolis, France

    Median Technologies Announces Rebranding of iBiopsy®, Changes Name to eyonis™

    Median Technologies today unveils a new identity, including a new name, logo, tagline for its iBiopsy® AI/ML tech-based suite of software as medical devices (SaMD) and business unit, as part of an extensive rebranding initiative. iBiopsy® becomes eyonis™.
    Read more Download 20231126_PR_eyonis_EN_final.pdf
  • 11/22/2023, Sophia-Antipolis, France

    Median Technologies to speak at the Radiological Society of North America 2023 Annual Meeting, Nov. 26 – 30, Chicago, IL, USA

    Median Technologies (ALMDT) announced today that the Company will be speaking and presenting at the world’s largest medical imaging conference, the Radiological Society of North America (RSNA) 2023 Annual Meeting and Scientific Assembly, being held in Chicago, IL, USA, Nov. 26-30, 2023.
    Read more Download 20231122_PR_RSNA2023_EN.pdf
  • 11/06/2023, Sophia Antipolis, France

    Disclosure of total number of voting rights and number of shares in the capital as of October 31st, 2023

    Disclosure of total number of voting rights and number of shares in the capital as of October 31st, 2023, pursuant to article L-223-8 II of the French “code de Commerce” and 223-16 of the AMF’s General Regulations.
    Read more Download 20231106_PR_shares_votingrights_Oct2023.pdf
  • 10/19/2023, Sophia Antipolis, France

    Median Technologies reports 2023 half-year results and business indicators for the third quarter of 2023

    Median Technologies (Euronext Growth – ALMDT:PA), whose board of Directors approved the consolidated IFRS financial statements for the first half of 2023 on October 18, 2023, today announces its half-year results as well as business indicators for Q3 2023 (unaudited).
    Read more Download 20231019_PR_H12023_final_EN.pdf
  • 10/17/2023, Sophia Antipolis, France

    First results of Median Technologies’ iBiopsy® HCC detection AI model developed on the PHELICAR Clinical Data Registry, to be presented at the ESMO Congress(Oct 20-24, 2023, Madrid, Spain)

    Median’s iBiopsy® AI model, designed to detect HCC lesions as small as 10 mm in diameter, showcased promising results, achieving an impressive sensitivity rate of 92% on the test set. This notable achievement significantly surpasses the average sensitivity of 69% observed among radiologists without AI/ML tech-based computer aided detection. The next phase of research will focus on the small-size lesions to improve the diagnosis of very early stage (0) and early-stage (A) HCC.
    Read more Download 20231017_PR_Phelicar_ESMO_final_EN.pdf
  • 10/16/2023, Sophia Antipolis, France

    Median Technologies’ Global iCRO Team to participate in the 2023 ESMO Congress, Oct 20 – 24, 2023, Madrid, Spain

    The iCRO team will be available at Booth #552, Exhibition Hall 5 during the entire industry exhibition duration. Members of the Median Technologies’ team across the globe, including China, United States, and Europe, will be in attendance.
    Read more Download 20231016_PR_ESMOiCRO_EN.pdf
  • 10/10/2023, Sophia Antipolis, France

    Median Technologies appoints Ben McDonald to its Board of Directors

    Median Technologies announced today that Ben McDonald has joined its Board of Directors, chaired by Oran Muduroglu. This appointment was approved during the ordinary shareholders’ meeting, held on October 10th.
    Read more Download 20231010_PR_BenMcDonald_appointment.pdf
  • 10/06/2023, Sophia Antipolis, France

    Disclosure of total number of voting rights and number of shares in the capital as of September 30th, 2023

    Disclosure of total number of voting rights and number of shares in the capital as of September 30th, 2023, pursuant to article L-223-8 II of the French “code de Commerce” and 223-16 of the AMF’s General Regulations.
    Read more Download 20231006_PR_shares_votingrights_Sep2023.pdf
  • 09/22/2023, Sophia Antipolis, France

    Median Technologies announces the availability of the preparatory documents for the Shareholders’ Ordinary General Meeting on October 10, 2023

    The shareholders of Median Technologies (ALMDT:PA) are invited to participate at the Shareholders’ Ordinary General Meeting which will be held on Tuesday October 10, 2023, at 11:00 AM CEST at PDGB, 174 avenue Victor Hugo – 75116 Paris.
    Read more Download 20230922_PR_OGM_20231010_EN.pdf
    • 1 … 35